Exploring signals of myopathy associated with statin and contraindicated comedications in the realworld

Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis

(2022) Masayuki Chuma et al.   CLINICAL INFECTIOUS DISEASES

Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source

(2021) Yoshihiro Noguchi et al.   BRIEFINGS IN BIOINFORMATICS

Case–non-case studies: Principle, methods, bias and interpretation

(2019) Jean-Luc Faillie   THERAPIE

Analysis of drug–drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database

(2018) Nimish Patel et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   EUROPEAN HEART JOURNAL

The role of mitochondria in statin-induced myopathy

(2015) Maria Apostolopoulou et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Co-Medication of Statins with Contraindicated Drugs

(2015) Bo Ram Yang et al.   PLoS One

Phenotype Standardization for Statin-Induced Myotoxicity

(2014) A Alfirevic et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption

(2012) Yoshihisa Shitara et al.   BIOPHARMACEUTICS & DRUG DISPOSITION

Statin drug interactions and related adverse reactions

(2012) Stefano Bellosta et al.   Expert Opinion On Drug Safety

A statistical methodology for drug–drug interaction surveillance

(2008) G. Niklas Norén et al.   STATISTICS IN MEDICINE